Infusion Options recalls

Infusion Options has 76 recalls on record with the FDA and USDA, the earliest in 2019 and the latest reported on 21 Aug 2019. The most frequent reason is sterility.

Total recalls76since 2019

Last 12 months0reported

Class I00% of total

Ongoing0latest 21 Aug 2019

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 76 100%Class III 0 0%

Why infusion options is recalled

Sterility76100%

Product types

By year

201976100%

All infusion options recalls, newest first

76 total

Reported	Class	Recall	Company	Reason	Where
21 Aug 2019Drug	CLASS II	Pembrolizumab 200 MG / Ns Ivpb recalled by Infusion Options	Infusion Options	Sterility	NY
21 Aug 2019Drug	CLASS II	Calcium Gluconate 1 Gm / Nacl 9% Ivpb recalled by Infusion Options	Infusion Options	Sterility	NY
21 Aug 2019Drug	CLASS II	Oxaliplatin 145 MG / D5w Ivpb recalled by Infusion Options	Infusion Options	Sterility	NY
21 Aug 2019Drug	CLASS II	Cetuximab 335 MG / Ivpb recalled by Infusion Options	Infusion Options	Sterility	NY
21 Aug 2019Drug	CLASS II	Eribulin 12 MG / Ns Ivpb recalled by Infusion Options	Infusion Options	Sterility	NY
21 Aug 2019Drug	CLASS II	Decitabine 40 MG / Ns Ivpb recalled by Infusion Options	Infusion Options	Sterility	NY
21 Aug 2019Drug	CLASS II	Fluorouracil 560 MG / IVP recalled by Infusion Options	Infusion Options	Sterility	NY
21 Aug 2019Drug	CLASS II	Carboplatin 174 MG / Ns Ivpb recalled by Infusion Options	Infusion Options	Sterility	NY
21 Aug 2019Drug	CLASS II	Oxytocin Lactated Ringers Intravenous Solution recalled	Infusion Options	Sterility	NY
21 Aug 2019Drug	CLASS II	Darzalex 1008 MG / Ns Ivpb recalled by Infusion Options	Infusion Options	Sterility	NY

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.